Nisa Investment Advisors’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Nisa Investment Advisors’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,527	Closed	-$617K	–	2398
2020 Q3	$617K	Sell	4,527 -1,815	-29%	-$193K	0.01%	974
2020 Q2	$613K	Buy	6,342 +1,277	+25%	+$107K	0.01%	950
2020 Q1	$237K	Buy	5,065 +70	+1%	+$4.49K	﹤0.01%	1144
2019 Q4	$364K	Hold	4,995	–	–	﹤0.01%	1188
2019 Q3	$260K	Buy	4,995 +4,820	+2,754%	+$256K	﹤0.01%	1260
2019 Q2	$9K	Hold	175	–	–	﹤0.01%	1796
2019 Q1	$9K	Sell	175 -125	-42%	-$5.76K	﹤0.01%	1802
2018 Q4	$15K	Buy	+300	New	+$16.5K	﹤0.01%	1559

Nisa Investment Advisors's MYOK Position: Q4 2020 in Review

Nisa Investment Advisors sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 4,527 shares — an estimated $617K sold.

Nisa Investment Advisors first reported a position in MYOK in Q4 2018 and held it in 8 quarters. The position peaked at $617K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Nisa Investment Advisors reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Nisa Investment Advisors sold 4,527 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $617K.
Nisa Investment Advisors first reported a position in MyoKardia, Inc. Common Stock in Q4 2018 and held it in 8 quarters.
Nisa Investment Advisors's MyoKardia, Inc. Common Stock position peaked at $617K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Nisa Investment Advisors's 13F filing for Q4 2020, filed 25 Jan 2021.